High Sensitivity Optical Methods to Detect Measles Virus

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 200-2012-53384
Agency Tracking Number: HHS200201253384
Amount: $579,970.00
Phase: Phase II
Program: SBIR
Awards Year: 2012
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
Argents Diagnostics, Inc.
Athens, GA, 30602-
DUNS: 827672382
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Richard Dluhy
Business Contact
 Richard Dluhy
Email: rdluhy@argentdiagnostics.com
Research Institution
A rapid respond to outbreaks critically depends on laboratory confirmation of suspected measles cases. In general, the turnaround times for serologic test results provided by the WHO Measles/Rubella Laboratory Network are adequate; however, results from specimens collected in remote areas can be delayed due to poor infrastructure for collection, storage and transportation of specimens. For this reason, diagnostic assays that can be performed in field conditions may be necessary for rapid outbreak confirmation and response in some settings. There is no plan to replace the standard diagnostic approaches with rapid filed tests and results from rapid filed tests will always be confirmed in the national laboratory. However, in some settings, the availability of a rapid test would improve the timing of the public health response to an outbreak. Rapid response to measles outbreaks is critical. Argent Diagnostics has developed a bench top assay using surface enhanced raman spectroscopy (SERS) to detect measles virus that is sensitive and specific. The lower limit of detection of measles virus in a clinical sample is equivalent to that of RT-PCR. The assay can also identify the genotype of measles and could distinguish between vaccine and wild-type strains. As part of the Phase II project, Argent will adapt the measles assay to a convenient hand held device that could be used as a rapid field test in resource limited settings.The hand held device is available commercially and is being adapted for field tests for a number of viral pathogens including influenza, respiratory syncytial virus, Hendra virus and Nipah virus. Success of the Phase II project would attract funding from the Bill and Melinda Gates Foundation and private companies interested in commercial viral diagnostics

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government